» Articles » PMID: 29535893

Temporal Changes in Care Processes and Outcomes for Endovascular Treatment of Acute Ischemic Stroke: Retrospective Registry Data from Three Korean Centers

Overview
Date 2018 Mar 15
PMID 29535893
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: The purpose of the current study is to evaluate the influence of temporal patterns related to the availability of new endovascular treatment (EVT) devices on care processes and outcomes among patients with AIS.

Materials And Methods: We enrolled 720 consecutive patients (January 2011 to May 2016) in a retrospective registry, ASIAN KR, from three Korean hospitals, who received EVT for acute ischemic stroke (AIS) caused by cervicocephalic arterial occlusions. We performed period-to-period analyses based on stent retriever reimbursement and the availability of second-generation direct-aspiration devices (Period 1: January 2011-July 2014 vs. Period 2: August 2014-May 2016); time metrics and outcomes were compared when the onset-to-puncture time was <720 min among patients with EVT for intracranial occlusion.

Results: Period 2 had better post-EVT outcomes (3-month modified Rankin Scale 0-2 or equal to prestroke score, 48.3% vs. 60.2%, P=0.004), more successful reperfusion rates (modified Treatment In Cerebral Ischemia 2b-3, 74.2% vs. 82.2%, P=0.019), fewer subarachnoid hemorrhages (modified Fisher grade 3-4, 5.5% vs. 2.0%, P=0.034) and lower hemorrhagic transformation rates (any intracerebral hemorrhage, 35.3 vs. 22.7%, P=0.001) than Period 1. Compared to Period 1, Period 2 had a shorter door-to-puncture time (median 109 vs. 90 min, P<0.001), but longer onset-to-door time (129 vs. 143 min, P=0.057).

Conclusion: Recent temporal improvements in post-EVT AIS outcomes in Korea are likely due to a combination of enhanced hospital care processes and administration of newer thrombectomy devices.

Citing Articles

Nelonemdaz and Patients With Acute Ischemic Stroke and Mechanical Reperfusion: The RODIN Randomized Clinical Trial.

Lee J, Kang H, Ahn S, Song T, Shin D, Bae H JAMA Netw Open. 2025; 8(1):e2456535.

PMID: 39874036 PMC: 11775734. DOI: 10.1001/jamanetworkopen.2024.56535.


Intracranial hemorrhage risk in patients with cerebral microbleeds after mechanical thrombectomy for acute ischemic stroke: a systematic review and meta-analysis.

Guo T, Ma T, Bai X, Wang J, Wang Y Neurol Sci. 2024; 45(7):3021-3029.

PMID: 38351360 DOI: 10.1007/s10072-024-07393-z.


Atrial Fibrillation and Reperfusion Therapy in Acute Ischaemic Stroke Patients: Prevalence and Outcomes-A Comprehensive Systematic Review and Meta-Analysis.

Patel J, Bhaskar S Neurol Int. 2023; 15(3):1014-1043.

PMID: 37755356 PMC: 10537209. DOI: 10.3390/neurolint15030065.


The Rescue on Reperfusion Damage in Cerebral Infarction by Nelonemdaz (RODIN) Trial: Protocol for a Double-Blinded Clinical Trial of Nelonemdaz in Patients with Hyperacute Ischemic Stroke and Endovascular Thrombectomy.

Lee J, Lee J, Gwag B, Choi D, An C, Kang H J Stroke. 2023; 25(1):160-168.

PMID: 36746385 PMC: 9911845. DOI: 10.5853/jos.2022.02453.


Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.

Hong J, Lee J, Lee Y, Shin D, Shin D, Hwang Y Stroke. 2022; 53(11):3250-3259.

PMID: 36065810 PMC: 9586831. DOI: 10.1161/STROKEAHA.122.039649.


References
1.
Jeon S, Ryoo S, Lee D, Kwon S, Jang S, Lee E . Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis. J Stroke. 2017; 19(2):196-204. PMC: 5466296. DOI: 10.5853/jos.2016.01802. View

2.
Nogueira R, Lutsep H, Gupta R, Jovin T, Albers G, Walker G . Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012; 380(9849):1231-40. PMC: 4176618. DOI: 10.1016/S0140-6736(12)61299-9. View

3.
Liebeskind D, Feldmann E . Data considerations in ischemic stroke trials. Neurol Res. 2014; 36(5):423-6. PMC: 4156583. DOI: 10.1179/1743132814Y.0000000357. View

4.
Frontera J, Claassen J, Schmidt J, Wartenberg K, Temes R, Connolly Jr E . Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006; 59(1):21-7. DOI: 10.1227/01.neu.0000243277.86222.6c. View

5.
Campbell B, Mitchell P, Kleinig T, Dewey H, Churilov L, Yassi N . Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372(11):1009-18. DOI: 10.1056/NEJMoa1414792. View